LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,639 | -17.5% | 27,350 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $1,986 | -2.4% | 27,550 | -0.4% | 0.00% | -20.0% |
| Q1 2023 | $2,034 | +8.5% | 27,650 | -1.4% | 0.01% | 0.0% |
| Q4 2022 | $1,874 | -99.9% | 28,050 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $2,415,000 | -3.2% | 28,050 | +0.4% | 0.01% | 0.0% |
| Q2 2022 | $2,494,000 | -20.4% | 27,950 | +0.4% | 0.01% | 0.0% |
| Q1 2022 | $3,133,000 | -27.2% | 27,850 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $4,302,000 | +11.7% | 27,850 | +0.7% | 0.01% | 0.0% |
| Q3 2021 | $3,852,000 | +29.3% | 27,650 | +21.8% | 0.01% | +33.3% |
| Q2 2021 | $2,978,000 | -14.0% | 22,700 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $3,461,000 | +24.7% | 22,700 | -18.6% | 0.01% | +16.7% |
| Q4 2020 | $2,775,000 | +4.0% | 27,900 | -0.4% | 0.01% | 0.0% |
| Q3 2020 | $2,669,000 | -14.8% | 28,000 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $3,132,000 | +53.8% | 28,000 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $2,036,000 | -30.3% | 28,000 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $2,920,000 | +5.1% | 28,000 | +0.4% | 0.01% | 0.0% |
| Q3 2019 | $2,777,000 | -12.8% | 27,900 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $3,185,000 | -9.2% | 27,900 | 0.0% | 0.01% | -11.1% |
| Q1 2019 | $3,507,000 | -10.9% | 27,900 | -3.8% | 0.01% | -18.2% |
| Q4 2018 | $3,935,000 | -62.3% | 29,000 | -23.7% | 0.01% | -54.2% |
| Q3 2018 | $10,431,000 | +36.4% | 38,001 | +3.0% | 0.02% | +26.3% |
| Q2 2018 | $7,645,000 | +25.9% | 36,901 | +0.4% | 0.02% | +26.7% |
| Q1 2018 | $6,070,000 | +15.9% | 36,754 | -3.9% | 0.02% | +25.0% |
| Q4 2017 | $5,238,000 | +2.0% | 38,254 | +1.4% | 0.01% | -7.7% |
| Q3 2017 | $5,137,000 | +13.7% | 37,733 | +1.3% | 0.01% | +8.3% |
| Q2 2017 | $4,520,000 | +9.4% | 37,233 | -4.6% | 0.01% | +9.1% |
| Q1 2017 | $4,131,000 | +1.8% | 39,033 | -2.3% | 0.01% | 0.0% |
| Q4 2016 | $4,058,000 | -4.9% | 39,933 | -4.5% | 0.01% | 0.0% |
| Q3 2016 | $4,269,000 | -15.0% | 41,833 | -0.7% | 0.01% | -15.4% |
| Q2 2016 | $5,025,000 | +20.5% | 42,133 | +8.2% | 0.01% | +18.2% |
| Q1 2016 | $4,169,000 | -1.2% | 38,933 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $4,221,000 | +53.0% | 38,933 | +20.8% | 0.01% | +37.5% |
| Q3 2015 | $2,759,000 | -2.1% | 32,216 | +15.3% | 0.01% | +14.3% |
| Q2 2015 | $2,818,000 | +31.3% | 27,930 | +0.4% | 0.01% | +40.0% |
| Q1 2015 | $2,146,000 | -21.2% | 27,830 | -45.6% | 0.01% | +66.7% |
| Q4 2014 | $2,722,000 | +468.3% | 51,174 | +402.3% | 0.00% | +200.0% |
| Q3 2014 | $479,000 | -20.6% | 10,188 | +5.2% | 0.00% | -50.0% |
| Q2 2014 | $603,000 | -7.5% | 9,688 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $652,000 | +36.4% | 9,688 | +6.6% | 0.00% | +100.0% |
| Q4 2013 | $478,000 | – | 9,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |